Zi-Shan Hou

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Genetic factors contribute to patient-specific warfarin dose for Han Chinese

Tingliang Wang, Honglei Li, Wen-Ye Tjong et al. · Clinica Chimica Acta · 2008 · 58 citations

Medicine, Genetics, Pharmacology +16

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

Junbo Ge, Fan Wei-hu, Jingmin Zhou et al. · Chinese Medical Journal · 2020 · 45 citations · Full text

Medicine, Cardiology, Pharmacology +15

[Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial].

Wang Ai-hu, Jielin Pu, Xiaoyong Qi et al. · PubMed · 2011 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +10